Trademark: 97033394
Status Date
Tuesday, April 11, 2023
Registration Number
7021995
Registration Date
Tuesday, April 11, 2023
Filing Date
Friday, September 17, 2021
Published for Opposition
Tuesday, January 24, 2023
42 Development of platform technology, namely, immunotherapy pharmaceutical platforms for use in manufacturing therapeutics related to inflammaging, inflammatory diseases, age-related diseases and cancer; Medical and scientific research and development services in the field of protein therapeutics and immunotherapeutics; pharmaceutical product development; pharmaceutical research and development services; Research and development of pharmaceuticals for the treatment of age-related and inflammatory diseases and cancer
Apr 11, 2023
Notice Of Registration Confirmation Emailed
Apr 11, 2023
Registered-Principal Register
Jan 24, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Published For Opposition
Jan 4, 2023
Notification Of Notice Of Publication E-Mailed
Dec 22, 2022
Approved For Pub - Principal Register
Dec 22, 2022
Examiner's Amendment Entered
Dec 22, 2022
Notification Of Examiners Amendment E-Mailed
Dec 22, 2022
Examiners Amendment E-Mailed
Dec 22, 2022
Examiners Amendment -Written
Jun 23, 2022
Notification Of Non-Final Action E-Mailed
Jun 23, 2022
Non-Final Action E-Mailed
Jun 23, 2022
Non-Final Action Written
Jun 21, 2022
Assigned To Examiner
Oct 28, 2021
Preliminary/Voluntary Amendment - Entered
Oct 28, 2021
Assigned To Lie
Oct 5, 2021
Teas Voluntary Amendment Received
Oct 22, 2021
New Application Office Supplied Data Entered
Sep 21, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
